Where does Mehdi Pirouz work?

Mehdi Pirouz is Venture Partner at SF500.

What check size does Mehdi Pirouz write?

Mehdi Pirouz typically writes checks of $50 – $1M.

Where did Mehdi Pirouz go to school?

Mehdi Pirouz studied at Harvard Medical School (Postdoctoral Fellow, RNA Medicine); Max Planck Institute for Multidisciplinary Sciences (Postdoctoral Fellow); Max Planck Institute for Multidisciplinary Sciences (Doctor of Philosophy - PhD, Stem Cell Biology and Functional Genomics).

Mehdi Pirouz

Investor

Venture Partner at SF500

San Mateo, California

Writes $50 – $1M checks · typically $250K

About

Mehdi Pirouz is CEO and Co-Founder of Noara Therapeutics, a biotechnology company developing therapeutic approaches for chronic and complex diseases. He brings over 25 years of experience in academia and industry, including a faculty position at Harvard Medical School, with expertise in molecular biology, platform development, and discovery pipelines combining synthetic biology, high-throughput screening, and computational design.

Experience

Noara TherapeuticsCEO and Co-Foundercurrent2025 — presentCambridge, Massachusetts, United States
Orna TherapeuticsAssociate Director | Head of Molecular Biology2023 — 2024Watertown, Massachusetts, United States
Sail BiomedicinesPrincipal Scientist2023
Sail BiomedicinesSenior Scientist II2022 — 2023
Rutgers Robert Wood Johnson Medical SchoolAssistant Professor2021 — 2022Piscataway, New Jersey, United States
Harvard Medical SchoolInstructor In Medicine2020 — 2021Boston, Massachusetts, United States

Skills & more

Python (Programming Language)LeadershipStrategic Leadership2Entrepreneurship2Structural Biology2RNA1Team Building1BioinformaticsAssay DevelopmentBiotechnologyResearch and Development (R&D)Project Management

+12 more

High Throughput ScreeningMachine LearningCell BiologyMolecular BiologyCell CultureWestern BlottingConfocal MicroscopyMolecular CloningEmbryonic Stem CellsRNA-seqgerm cellsCo-Immunoprecipitation

Languages English

From Mehdi's professional profile.

Colleagues at SF500

Juan Carlos Soria

Managing Partner at SF500

Frequently asked questions

Who is Mehdi Pirouz?: Mehdi Pirouz is CEO and Co-Founder of Noara Therapeutics, a biotechnology company developing therapeutic approaches for chronic and complex diseases. He brings over 25 years of experience in academia and industry, including a faculty position at Harvard Medical School, with expertise in molecular biology, platform development, and discovery pipelines combining synthetic biology, high-throughput screening, and computational design.
Where does Mehdi Pirouz work?: Mehdi Pirouz is Venture Partner at SF500.
What check size does Mehdi Pirouz write?: Mehdi Pirouz typically writes checks of $50 – $1M.
Where did Mehdi Pirouz go to school?: Mehdi Pirouz studied at Harvard Medical School (Postdoctoral Fellow, RNA Medicine); Max Planck Institute for Multidisciplinary Sciences (Postdoctoral Fellow); Max Planck Institute for Multidisciplinary Sciences (Doctor of Philosophy - PhD, Stem Cell Biology and Functional Genomics).

Same school

Also attended Harvard Medical School143

Niko BonatsosVerdict Capital founder and pre-consensus investor formerly at General Catalyst Anthony PhilippakisInvestor at GV (Google Ventures)Ben RobbinsInvestor at GV (Google Ventures)David ReshefInvestor at GV (Google Ventures)Krishna YeshwantInvestor at GV (Google Ventures)Morgan CheathamPartner and Head of Healthcare and Life Sciences at Breyer Capital

+ 137 more

Shared employers

+ 163 more

About

Experience

Skills & more

Colleagues at SF500

Frequently asked questions

Same school

Also attended Harvard Medical School143

Shared employers

Also worked at Orna Therapeutics1

Also worked at Sail Biomedicines3

Also worked at Rutgers Robert Wood Johnson Medical School2

Also worked at Harvard Medical School169